- Home
- RCKT vs NMM Comparison
RCKT vs NMM Comparison
Compare RCKT & NMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- NMM
- Stock Information
- Founded
- RCKT 1999
- NMM 2007
- Country
- RCKT United States
- NMM Greece
- Employees
- RCKT N/A
- NMM N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- NMM Marine Transportation
- Sector
- RCKT Health Care
- NMM Consumer Discretionary
- Exchange
- RCKT Nasdaq
- NMM Nasdaq
- Market Cap
- RCKT 326.4M
- NMM 959.8M
- IPO Year
- RCKT N/A
- NMM 2007
- Fundamental
- Price
- RCKT $2.48
- NMM $37.53
- Analyst Decision
- RCKT Buy
- NMM Strong Buy
- Analyst Count
- RCKT 13
- NMM 1
- Target Price
- RCKT $18.50
- NMM $80.00
- AVG Volume (30 Days)
- RCKT 4.7M
- NMM 95.9K
- Earning Date
- RCKT 08-04-2025
- NMM 08-19-2025
- Dividend Yield
- RCKT N/A
- NMM 0.53%
- EPS Growth
- RCKT N/A
- NMM N/A
- EPS
- RCKT N/A
- NMM 11.16
- Revenue
- RCKT N/A
- NMM $1,319,623,000.00
- Revenue This Year
- RCKT N/A
- NMM N/A
- Revenue Next Year
- RCKT N/A
- NMM $7.93
- P/E Ratio
- RCKT N/A
- NMM $3.38
- Revenue Growth
- RCKT N/A
- NMM 0.28
- 52 Week Low
- RCKT $2.19
- NMM $28.37
- 52 Week High
- RCKT $26.98
- NMM $65.89
- Technical
- Relative Strength Index (RSI)
- RCKT 31.96
- NMM 43.84
- Support Level
- RCKT $2.50
- NMM $39.87
- Resistance Level
- RCKT $2.70
- NMM $39.41
- Average True Range (ATR)
- RCKT 0.20
- NMM 1.25
- MACD
- RCKT 0.11
- NMM -0.28
- Stochastic Oscillator
- RCKT 4.82
- NMM 0.00
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About NMM Navios Maritime Partners LP Common Units Representing Limited Partner Interests
Navios Maritime Partners LP is a seaborne shipping company. It owns and operates dry cargo and container vessels with the primary long-term and staggered expiration charters. The firm's fleet consists of Ultra- Handymax, Panamax, Capsize, and Container vessels and categorized in Drybulk and Container vessels. It earns revenue through the chartering of vessels and voyage contracts. Geographically, it generates majority revenue from Asia.